METis TechBio

Hangzhou, China · Founded 2020 · In IPO Registration

Developer of an artificial intelligence platform designed to optimize pharmaceutical formulation processes. METis TechBio is based in Hangzhou, China and was founded in 2020. It has raised $315 million.

Last price · $/share
—
Implied valuation
—
Total raised
$314.7M
Last round
—
Valuation — not yet established

No valuation for METis TechBio is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($314.7M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of METis TechBio with a free account
  • ·The complete investor list: 19 names
  • ·Watch METis TechBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

METis TechBio funding history

No rounds on record

No funding rounds for METis TechBio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How METis TechBio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For METis TechBio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about METis TechBio

How much has METis TechBio raised?
METis TechBio has raised $314.7M in total funding across its recorded rounds.